<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Mon, 08 Jun 2026 02:59:36 -0400--><rss version="2.0">
    <channel>
        <title>Virax Biolabs Group Limited () Presentations</title>
        <link>https://ir.viraxbiolabs.com/company-information/presentations/rss</link>
        <description></description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/viraxbiolabs/files/theme/images/logo-300px.png</url>
                <title>Virax Biolabs Group Limited Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[Investor Presentation]]></title>
                <description><![CDATA[]]></description>
                <link>https://d1io3yog0oux5.cloudfront.net/_18e40384bcda3531b518bb35138e0550/viraxbiolabs/db/2309/21663/pdf/Virax+Biolabs+Investor+Deck+-+Q2+2026.pdf</link>
                <pubDate>Tue, 14 Apr 26 00:00:00 -0400</pubDate>
                <guid>https://d1io3yog0oux5.cloudfront.net/_18e40384bcda3531b518bb35138e0550/viraxbiolabs/db/2309/21663/pdf/Virax+Biolabs+Investor+Deck+-+Q2+2026.pdf</guid>
                                                                            </item>
            </channel>
</rss>